Jurgen Weinreich
Tuebingen, BW 72076, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A multi-nozzle nebuliser does not improve tissue drug delivery during PIPAC.
Journal: Surgical endoscopy
Published: May 25, 2024
Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: comparison of an experimental duplex drug to standard drug regimens in vitro.
Journal: Investigational new drugs
Published: May 22, 2018
Pharmacodynamics of Oxaliplatin-Derived Platinum Compounds During Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Emerging Aspect Supporting the Rational Design of Treatment Protocols.
Journal: Annals of surgical oncology
Published: December 06, 2016
Growth hormone abolishes the negative effects of everolimus on intestinal wound healing.
Journal: World journal of gastroenterology
Published: January 09, 2016
Growth and Chemosensitivity of Gastric Adenocarcinoma and Non-Malignant Cell Lines in Response to Novel Anti-Cancer Drug Combinations.
Journal: Chemotherapy
Published: April 27, 2015
Cytostatic activity of a 5-fluoro-2'-deoxyuridine-alendronate conjugate against gastric adenocarcinoma and non-malignant intestinal and fibroblast cell lines.
Journal: Anticancer research
Published: October 13, 2012
Cytostatic activity of the duplex drug linking 2'-deoxy-5-fluorouridine (5FdU) with 3'-C-ethynylcytidine (ECyd) against gastric adenocarcinoma cell lines.
Journal: Investigational new drugs
Published: May 25, 2010
Showing 1-8 of 8
Last Updated: 09/26/2026